Clinical Reasoning Analysis
The assessment finding that is most concerning and requires immediate nursing intervention is
new onset confusion with a blood glucose level of 45 mg/dL. This combination represents a critical, life-threatening state of
neuroglycopenia that demands urgent action to prevent permanent neurological injury or death.
In the context of a client newly diagnosed with pancreatic cancer, this presentation is a classic red flag for an underlying
insulinoma, a rare functional neuroendocrine tumor of the pancreatic islet cells. Insulinomas produce excessive, uncontrolled amounts of insulin, driving glucose out of the bloodstream and into cells, which results in profound hypoglycemia [1, 2]. The brain is almost entirely dependent on a continuous supply of glucose for energy; when the blood glucose drops to a level as low as
45 mg/dL, the central nervous system is starved of its primary fuel. This triggers neuroglycopenic symptoms, which include confusion, altered consciousness, seizures, and, if uncorrected, coma
[2]. The clinical presentation can be dangerously deceptive, often mimicking primary neurological or psychiatric conditions such as stroke, acute psychosis, or, as noted in the literature, even migraine, which leads to frequent misdiagnosis [1, 2]. The nurse must recognize that the confusion is not a separate issue but a direct consequence of the critically low glucose level and a sign of severe brain glucose deprivation.
This scenario is distinct from the more gradual metabolic changes associated with pancreatic cancer. While weight loss and obstructive jaundice (indicated by clay-colored stools and dark urine) are classic and concerning signs of a pancreatic head malignancy causing biliary obstruction, they represent subacute to chronic processes. These findings require thorough investigation and management but do not pose the same immediate, minute-to-minute threat to airway, breathing, and circulation as severe hypoglycemia. The priority is to address the immediate physiological crisis. The International Guidelines for the Diagnosis and Management of Hyperinsulinism emphasize that the primary goal in such a presentation is the rapid identification and correction of hypoglycemia to prevent neurological damage
[4]. The nurse’s immediate intervention must be to verify the blood glucose level with a point-of-care test and administer a rapid-acting source of glucose, typically intravenous dextrose, as per protocol, while monitoring the client’s level of consciousness and vital signs closely. The presence of an insulinoma is biochemically confirmed when symptomatic hypoglycemia is coupled with inappropriately high levels of insulin and C-peptide, a diagnostic process often completed during a supervised fast [2, 4].
References (research sources)
- [2]
Insulinoma initially misdiagnosed as migraine.Research articleHameed J, Ahmed I, Zaitoun AM, Syed AS, Santos C, Chee C. (2025) · DOI: 10.22551/2025.48.1203.10325
- [4]
International Guidelines for the Diagnosis and Management of Hyperinsulinism.GuidelineDe Leon DD, Arnoux JB, Banerjee I, Bergada I, Bhatti T, Conwell LS, Fu J, Flanagan SE, Gillis D, Meissner T, Mohnike K, Pasquini TLS, Shah P, Stanley CA, Vella A, Yorifuji T, Thornton PS. (2024) · DOI: 10.1159/000531766